Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001641172-25-005054·Can-Fite BioPharma Ltd.
Schedule 13G ownership disclosure
CAN FITE BIOFARMA LTD
Ordinary Shares, no par value · CUSIP: 13471N300
Event date: 2025-04-14
- Filing-level shares
- 375,000,000.00
- Percent of class
- 9.7%
- Orca Capital AG
Shares: 375,000,000.00 · Class: 9.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001641172-25-005054
- Form type
- SCHEDULE 13G
- Filer
- Can-Fite BioPharma Ltd.
- CIK
- CIK 1536196
- Filed
- Apr 16, 2025
- Reporting period
- Apr 14, 2025
- Description
- Schedule 13G beneficial ownership